Loading...

SAB Biotherapeutics, Inc.

SABS•NASDAQ
Healthcare
Biotechnology
$2.61
$-0.09(-3.33%)

SAB Biotherapeutics, Inc. (SABS) Stock Chart & Performance Analysis

Explore SAB Biotherapeutics, Inc.’s stock chart, historical data, and performance trends for a deeper market understanding.

1-Day Change
-7.48%
5-Day Change
2.17%
1-Month Change
-24.68%
3-Month Change
-69.40%
6-Month Change
-53.37%
Year-to-Date (YTD) Change
-68.33%
1-Year Change
-74.18%
3-Year Change
-95.53%
5-Year Change
-98.84%
All-Time (Max) Change
-98.84%

Analyzing SAB Biotherapeutics, Inc. (SABS) Trends Across Multiple Time Frames

SAB Biotherapeutics, Inc. Charts reveal critical insights by breaking down performance into different periods from short-term swings to long-term trends. SAB Biotherapeutics, Inc. stock shows -7.48% 1-day change, indicating low volatility, while its 5-day change of 2.17% suggests a broader trend. Over a 1-month period, a -24.68% drop could signal a pullback, whereas a 3-month decline of -69.40% may reflect broader market sentiment. Longer timeframes help assess sustained performance. A 6-month change of -53.37% and a YTD drop of -68.33% might concern investors, but a 1-year loss of -74.18% and a 3-year drop of -95.53% could indicate resilience. The 5-year surge of -98.84% highlights weak historical growth, while the all-time return of -98.84% underscores long-term potential. Whether tracking intraday moves or multi-year trends, analyzing these metrics helps traders and investors make data-driven decisions.

Frequently Asked Questions

;